Sterling Capital Management’s Heron Therapeutics HRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$7.65K	Buy	3,694 +1,848	+100%	+$3.83K	﹤0.01%	2288
2025 Q1	$4.06K	Sell	1,846 -1,778	-49%	-$3.91K	﹤0.01%	2268
2024 Q4	$5.55K	Buy	3,624 +3,275	+938%	+$5.01K	﹤0.01%	2433
2024 Q3	$695	Buy	+349	New	+$695	﹤0.01%	2718